Linked Life Data

10667645

Source:http://linkedlifedata.com/resource/pubmed/id/10667645

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10667645rdf:typepubmed:Citationlld:pubmed
pubmed-article:10667645lifeskim:mentionsumls-concept:C0028128lld:lifeskim
pubmed-article:10667645lifeskim:mentionsumls-concept:C0014025lld:lifeskim
pubmed-article:10667645lifeskim:mentionsumls-concept:C0126174lld:lifeskim
pubmed-article:10667645lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:10667645lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:10667645lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:10667645lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:10667645lifeskim:mentionsumls-concept:C0085973lld:lifeskim
pubmed-article:10667645lifeskim:mentionsumls-concept:C0007320lld:lifeskim
pubmed-article:10667645lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:10667645lifeskim:mentionsumls-concept:C0205227lld:lifeskim
pubmed-article:10667645pubmed:issue1lld:pubmed
pubmed-article:10667645pubmed:dateCreated2000-2-24lld:pubmed
pubmed-article:10667645pubmed:abstractTextPrognosis in Takayasu's arteritis is limited owing to renovascular hypertension. The authors report a patient with Takayasu's arteritis who had been unilaterally nephrectomized and presented with malignant hypertension due to renal artery stenosis. Hypertension was refractory to conventional antihypertensive treatment, and stenosis was not accessible by interventional angioplasty. Initiation of enalapril and losartan therapy was successful in improving blood pressure without deterioration of renal function due to ischemic failure. Antihypertensive treatment resulted in dramatically stimulated endogenous nitric oxide (NO) synthesis, while elevated plasma endothelin-1 levels were unchanged. Renovascular hypertension in Takayasu's arteritis is associated with an imbalance of vasoconstrictor peptide endothelin-1 and vasodilator peptide NO. Successful treatment of hypertension by enalapril or losartan results in improved endogenous NO synthesis, which putatively counterbalances excessive vasoconstrictor actions and may retard the progression of renal failure.lld:pubmed
pubmed-article:10667645pubmed:languageenglld:pubmed
pubmed-article:10667645pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10667645pubmed:citationSubsetIMlld:pubmed
pubmed-article:10667645pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10667645pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10667645pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10667645pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10667645pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10667645pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10667645pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10667645pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10667645pubmed:statusMEDLINElld:pubmed
pubmed-article:10667645pubmed:monthJanlld:pubmed
pubmed-article:10667645pubmed:issn0003-3197lld:pubmed
pubmed-article:10667645pubmed:authorpubmed-author:BaldamusC ACAlld:pubmed
pubmed-article:10667645pubmed:authorpubmed-author:PollokMMlld:pubmed
pubmed-article:10667645pubmed:authorpubmed-author:MarsenT ATAlld:pubmed
pubmed-article:10667645pubmed:authorpubmed-author:SukauGGlld:pubmed
pubmed-article:10667645pubmed:issnTypePrintlld:pubmed
pubmed-article:10667645pubmed:volume51lld:pubmed
pubmed-article:10667645pubmed:ownerNLMlld:pubmed
pubmed-article:10667645pubmed:authorsCompleteYlld:pubmed
pubmed-article:10667645pubmed:pagination69-75lld:pubmed
pubmed-article:10667645pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10667645pubmed:meshHeadingpubmed-meshheading:10667645...lld:pubmed
pubmed-article:10667645pubmed:meshHeadingpubmed-meshheading:10667645...lld:pubmed
pubmed-article:10667645pubmed:meshHeadingpubmed-meshheading:10667645...lld:pubmed
pubmed-article:10667645pubmed:meshHeadingpubmed-meshheading:10667645...lld:pubmed
pubmed-article:10667645pubmed:meshHeadingpubmed-meshheading:10667645...lld:pubmed
pubmed-article:10667645pubmed:meshHeadingpubmed-meshheading:10667645...lld:pubmed
pubmed-article:10667645pubmed:meshHeadingpubmed-meshheading:10667645...lld:pubmed
pubmed-article:10667645pubmed:meshHeadingpubmed-meshheading:10667645...lld:pubmed
pubmed-article:10667645pubmed:meshHeadingpubmed-meshheading:10667645...lld:pubmed
pubmed-article:10667645pubmed:meshHeadingpubmed-meshheading:10667645...lld:pubmed
pubmed-article:10667645pubmed:meshHeadingpubmed-meshheading:10667645...lld:pubmed
pubmed-article:10667645pubmed:meshHeadingpubmed-meshheading:10667645...lld:pubmed
pubmed-article:10667645pubmed:meshHeadingpubmed-meshheading:10667645...lld:pubmed
pubmed-article:10667645pubmed:meshHeadingpubmed-meshheading:10667645...lld:pubmed
pubmed-article:10667645pubmed:meshHeadingpubmed-meshheading:10667645...lld:pubmed
pubmed-article:10667645pubmed:meshHeadingpubmed-meshheading:10667645...lld:pubmed
pubmed-article:10667645pubmed:year2000lld:pubmed
pubmed-article:10667645pubmed:articleTitleEnalapril and losartan augment endogenous nitric oxide release in Takayasu's arteritis--a case report.lld:pubmed
pubmed-article:10667645pubmed:affiliationKlinik IV für Innere Medizin, University of Cologne, Germany. tobias.marsen@uni-koeln.delld:pubmed
pubmed-article:10667645pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10667645pubmed:publicationTypeCase Reportslld:pubmed